Large gap with delayed quotes
|
Last quote
01/20/2026
-
13:54:14
|
Bid
01/20/2026 -
14:01:51
|
Bid Volume |
Ask
01/20/2026 -
14:01:51
|
Ask Volume |
|---|---|---|---|---|
|
15.3200
-0.11
(
-0.71% )
|
15.3100
|
473 |
15.3300
|
828 |
Analysis date: 16.01.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 11.11.2025.
Interest
Weak
Weak
Two stars since 16.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 16.01.2026 at a price of 1570.00.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 07.11.2025.
4wk Rel Perf
-1.78%
-1.78%
The four-week dividend-adjusted underperformance versus STOXX600 is 1.78%.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.02%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.36%.
Mkt Cap in $bn
4.61
4.61
With a market capitalization between $2 & $8bn, HIKMA PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
1.58
1.58
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
8
8
The estimated PE is for the year 2027.
LT Growth
8.47%
8.47%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
4.19%
4.19%
The twelve month estimated dividend yield represents 33.46% of earnings forecasts.
Beta
58
58
For 1% of index variation, the stock varies on average by 0.58%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
124.81
124.81
The value at risk is estimated at GBp 124.81. The risk is therefore 7.95%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
11.10.2006
11.10.2006